PARP (Poly ADP-ribose Polymerase) Inhibitors Market Report

China PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Market Research Report 2023-2029

  • POSTDATE：Oct 06, 2023
  • PAGES：177
  • REPORT CODE：GMM1832987
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the PARP (Poly ADP-ribose Polymerase) Inhibitors industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • AstraZeneca

    • Pfizer

    • Clovis Oncology

    • Merck & Co

    By Type:

    • Talzenna

    • Zejula

    • Rubraca

    • Lynparza

    • Other

    By Application:

    • Other

    • Ovarian Cancer

    • Breast Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Overview 2018-2029

    • 1.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Development Overview

    • 1.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Development History

    • 1.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Market Size (2018-2029)

    • 1.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis by Type from Production Side

      • 1.4.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Talzenna (2018-2029)

      • 1.4.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Zejula (2018-2029)

      • 1.4.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Rubraca (2018-2029)

      • 1.4.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Lynparza (2018-2029)

      • 1.4.5 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • 1.5 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis by Application from Consumption End

      • 1.5.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

      • 1.5.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume, Sales Value and Growth Rate of Ovarian Cancer (2018-2029)

      • 1.5.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • 1.6 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis by Region

      • 1.6.1 North China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    Chapter 2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on PARP (Poly ADP-ribose Polymerase) Inhibitors Market Status and Competition at home and abroad in 2023

      • 2.2.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Status and Competition Analysis in 2023

      • 2.2.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China PARP (Poly ADP-ribose Polymerase) Inhibitors Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Development

    Chapter 3 PARP (Poly ADP-ribose Polymerase) InhibitorsIndustry Chain Analysis

    • 3.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Chain

    • 3.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the PARP (Poly ADP-ribose Polymerase) Inhibitors Market

    • 3.3 PARP (Poly ADP-ribose Polymerase) Inhibitors Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the PARP (Poly ADP-ribose Polymerase) Inhibitors Market

    Chapter 4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 4.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Total Production Volume and Growth Rate from Production Side

    • 4.5 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate, by Type

      • 4.5.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Talzenna

      • 4.5.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Zejula

      • 4.5.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Rubraca

      • 4.5.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Lynparza

      • 4.5.5 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Other

    Chapter 5 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China PARP (Poly ADP-ribose Polymerase) Inhibitors Total Market Size and Growth Rate from Consumption End

    • 5.5 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate, by Application

      • 5.5.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate of Other

      • 5.5.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate of Ovarian Cancer

      • 5.5.3 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate of Breast Cancer

    Chapter 6 China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Region

    • 6.1 China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Production Value, by Region

    • 6.2 China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume and Sales Value, by Region

    Chapter 7 North China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis

    • 7.1 North China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 7.2 North China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    Chapter 8 Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis

    • 8.1 Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 8.2 Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    Chapter 9 South China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis

    • 9.1 South China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 9.2 South China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    Chapter 10 East China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis

    • 10.1 East China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 10.2 East China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    Chapter 11 Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis

    • 11.1 Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 11.2 Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    Chapter 12 Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis

    • 12.1 Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 12.2 Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    Chapter 13 Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Analysis

    • 13.1 Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Type

    • 13.2 Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market, by Application

    Chapter 14 Company Profiles

      • 14.1 AstraZeneca

        • 14.1.1 AstraZeneca Company Profile

        • 14.1.2 AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer

        • 14.2.1 Pfizer Company Profile

        • 14.2.2 Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Clovis Oncology

        • 14.3.1 Clovis Oncology Company Profile

        • 14.3.2 Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Merck & Co

        • 14.4.1 Merck & Co Company Profile

        • 14.4.2 Merck & Co PARP (Poly ADP-ribose Polymerase) Inhibitors Market Performance

        • 14.4.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Research Conclusions

    • 15.2 PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Market Size (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Talzenna (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Zejula (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Rubraca (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Lynparza (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume, Production Value and Growth Rate of Other (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume, Sales Value and Growth Rate of Other (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume, Sales Value and Growth Rate of Ovarian Cancer (2018-2029)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure North China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure South China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure East China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate from 2018-2029

    • Figure PARP (Poly ADP-ribose Polymerase) Inhibitors Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type in 2018

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Type in 2023

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Talzenna (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Zejula (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Rubraca (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Lynparza (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume and Growth Rate of Other (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application in 2018

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Share by Application in 2023

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Total Market Size and Growth Rate from Consumption End

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate of Other (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate of Ovarian Cancer (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Region (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Region (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Region (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Value by Region (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Value Share by Region (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Value Share by Region (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Region (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Region (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Region (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Value by Region (2018-2023)

    • Table China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Value Share by Region (2018-2023)

    • Figure China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Value Share by Region (2018-2023)

    • Table North China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Type (2018-2023)

    • Table North China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure North China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Table North China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Application (2018-2023)

    • Table North China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure North China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Type (2018-2023)

    • Table Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Application (2018-2023)

    • Table Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Central China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table South China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Type (2018-2023)

    • Table South China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure South China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Table South China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Application (2018-2023)

    • Table South China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure South China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table East China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Type (2018-2023)

    • Table East China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure East China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Table East China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Application (2018-2023)

    • Table East China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure East China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Type (2018-2023)

    • Table Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Application (2018-2023)

    • Table Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Northeast China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Type (2018-2023)

    • Table Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Application (2018-2023)

    • Table Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Southwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume by Type (2018-2023)

    • Table Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Figure Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Production Volume Share by Type (2018-2023)

    • Table Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume by Application (2018-2023)

    • Table Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Figure Northwest China PARP (Poly ADP-ribose Polymerase) Inhibitors Sales Volume Share by Application (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Clovis Oncology Company Profile

    • Table Clovis Oncology PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Price and Gross (2018-2023)

    • Table Merck & Co Company Profile

    • Table Merck & Co PARP (Poly ADP-ribose Polymerase) Inhibitors Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US